YM178
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Overactive Bladder
Conditions
Overactive Bladder
Trial Timeline
— → Mar 1, 2007
NCT ID
NCT00337090About YM178
YM178 is a phase 2 stage product being developed by Astellas Pharma for Overactive Bladder. The current trial status is completed. This product is registered under clinical trial identifier NCT00337090. Target conditions include Overactive Bladder.
What happened to similar drugs?
10 of 20 similar drugs in Overactive Bladder were approved
Approved (10) Terminated (1) Active (9)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (6)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00337090 | Phase 2 | Completed |
| NCT01720212 | Phase 1 | Completed |
| NCT01334905 | Phase 1 | Completed |
| NCT00965926 | Phase 1 | Completed |
| NCT00840645 | Phase 3 | Completed |
| NCT00750620 | Phase 1 | Completed |
Competing Products
20 competing products in Overactive Bladder